Enzyme replacement therapy (Agalsidase alpha (Replagal®))

( DrugBank: Agalsidase alpha / KEGG DRUG: Agalsidase alfa )

1 disease

ID	Disease name (Link within this page)	Number of trials
19	Lysosomal storage disease	1

19. Lysosomal storage disease

Clinical trials : 899 / Drugs : 684 - (DrugBank : 99) / Drug target genes : 51 - Drug target pathways : 182

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02956954 (ClinicalTrials.gov)	March 25, 2017	3/11/2016	Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease	Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease (AFD): Impact of ...	Anderson-Fabry Disease	Drug: Enzyme replacement therapy (Agalsidase alpha (Replagal®));Procedure: Magnetic Resonance Imagin ...	University Hospital, Rouen	NULL	Unknown status	18 Years	N/A	All	25	N/A	France

First Previous1Next Last